Polysaccharide-based artificial eardrum patch
Patent Information
- Application Number
- EP2023913335
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-12-30
- Filing Date
- 2023-12-28
- Publication Date
- 2025-04-02
AI Technical Summary
Current treatments for tympanic membrane perforations, such as myringoplasty or tympanoplasty, require invasive surgical procedures, are costly, and often result in incomplete regeneration and ethical/biosafety concerns, with grafts from patients not retaining the membrane effectively, especially in large perforations.
A polysaccharide-based artificial eardrum patch using a levan polymer, PCL polymer, and mesenchymal stem cells (MSCs) in a 3D bioprinted scaffold, with a coaxial electrospinning method for the first layer and a levan-alginate hydrogel in the second layer, to enhance cell proliferation, adhesion, and migration, aiming for outpatient treatment and improved membrane retention.
This approach promotes faster tissue regeneration, reduces the need for patient-derived tissue, and increases the success rate of membrane retention, offering a non-invasive, cost-effective alternative with enhanced bioactivity and reduced risks of contamination or chemical inhomogeneity.
Smart Images

Figure 00000017_0000 
Figure 00000017_0001 
Figure 00000018_0000